0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 101-120 of 683 Articles
JAMA Dermatology | 
Observation | 
Sunita C. Crittenden, MD; Juliana E. Gilbert, MD; Jeffrey P. Callen, MD
JAMA Dermatol. 2014;150(7):780-781. doi:10.1001/jamadermatol.2013.7198.

JAMA | 
From the JAMA Network | 
Anne R. Cappola, MD, ScM
JAMA. 2014;311(24):2532-2533. doi:10.1001/jama.2014.3808.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(24):2473. doi:10.1001/jama.2014.7364.

JAMA | 
Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(24):2472. doi:10.1001/jama.2014.7643.

JAMA | 
Original Investigation |  FREE
Richard D. Carvajal, MD; Jeffrey A. Sosman, MD; Jorge Fernando Quevedo, MD; et al.
JAMA. 2014;311(23):2397-2405. doi:10.1001/jama.2014.6096.
Includes: Supplemental Content

JAMA | 
Editorial | 
Anne R. Cappola, MD, ScM; Edward H. Livingston, MD
JAMA. 2014;311(22):2277-2278. doi:10.1001/jama.2014.6675.

JAMA | 
From the JAMA Network | 
Mary A. Andrews, MD; Patrick G. O’Malley, MD, MPH
JAMA. 2014;311(22):2326-2327. doi:10.1001/jama.2014.4563.

JAMA | 
news@JAMA | 
JAMA. 2014;311(22):2263. doi:10.1001/jama.2014.6495.

JAMA | 
Original Investigation |  FREE
Christianne L. Roumie, MD, MPH; Robert A. Greevy, PhD; Carlos G. Grijalva, MD, MPH; et al.
JAMA. 2014;311(22):2288-2296. doi:10.1001/jama.2014.4312.
Includes: Supplemental Content

JAMA | 
Research Letter |  FREE
Yaron Finkelstein, MD, ABCP(Dip); Erin M. Macdonald, MSc; Ping Li, PhD; et al.
JAMA. 2014;311(21):2231-2232. doi:10.1001/jama.2014.839.

JAMA Internal Medicine | 
Invited Commentary | 
Jeffrey Brent, MD, PhD
JAMA Intern Med. 2014;174(6):918-919. doi:10.1001/jamainternmed.2014.19.

JAMA Internal Medicine | 
Original Investigation | 
Matthew Miller, MD, ScD; Sonja A. Swanson, ScM; Deborah Azrael, PhD; et al.
JAMA Intern Med. 2014;174(6):899-909. doi:10.1001/jamainternmed.2014.1053.
Includes: CME, Supplemental Content

JAMA Ophthalmology | 
Ophthalmic Images | 
Jia-Kang Wang, MD; Ting-Yu Shih, MD
JAMA Ophthalmol. 2014;132(6):741. doi:10.1001/jamaophthalmol.2013.4885.

JAMA Internal Medicine | 
Case Report/Case Series | 
Emily Kern, MD; Lisa B. VanWagner, MD, MS; Guang-Yu Yang, MD, PhD; et al.
JAMA Intern Med. 2014;174(6):984-987. doi:10.1001/jamainternmed.2014.674.

JAMA Internal Medicine | 
Original Investigation | 
Bruce L. Davidson, MD, MPH; Sara Verheijen, BS; Anthonie W. A. Lensing, MD, PhD; et al.
JAMA Intern Med. 2014;174(6):947-953. doi:10.1001/jamainternmed.2014.946.

JAMA Dermatology | 
Observation | 
Maider Pretel, MD, PhD; Mercedes Iñarrairaegui, MD, PhD; José Miguel Lera, MD; et al.
JAMA Dermatol. 2014;150(6):664-666. doi:10.1001/jamadermatol.2013.6924.

JAMA Internal Medicine | 
Invited Commentary | 
June K. Robinson, MD
JAMA Intern Med. 2014;174(6):970-971. doi:10.1001/jamainternmed.2014.157.

JAMA Internal Medicine | 
Original Investigation | 
Wen-Qing Li, PhD; Abrar A. Qureshi, MD, MPH; Kathleen C. Robinson, PhD; et al.
JAMA Intern Med. 2014;174(6):964-970. doi:10.1001/jamainternmed.2014.594.
Includes: Supplemental Content

JAMA | 
From the JAMA Network | 
Cindy England Owen, MD
JAMA. 2014;311(20):2121-2122. doi:10.1001/jama.2014.2323.

JAMA | 
Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(20):2057. doi:10.1001/jama.2014.5759.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Tramadol and Hypoglycemia:  One More Thing to Worry About
Lewis S. Nelson, MD; David N. Juurlink, MD, PhD